141 related articles for article (PubMed ID: 8598469)
1. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
Mitchell BM; Stevens JG
J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
[TBL] [Abstract][Full Text] [Related]
2. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
3. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
Rouse BT; Miller LS; Turtinen L; Moore RN
J Immunol; 1985 Feb; 134(2):926-30. PubMed ID: 2981270
[TBL] [Abstract][Full Text] [Related]
5. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
Hendricks RL; Tumpey TM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
[TBL] [Abstract][Full Text] [Related]
6. Replacement of glycoprotein B gene in the herpes simplex virus type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus.
Kostál M; Bacík I; Rajcáni J; Kaerner HC
Acta Virol; 1994 Apr; 38(2):77-88. PubMed ID: 7976866
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
Rager-Zisman B; Allison AC
J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
[TBL] [Abstract][Full Text] [Related]
8. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
Chrisp CE; Sunstrum JC; Averill DR; Levine M; Glorioso JC
Lab Invest; 1989 Jun; 60(6):822-30. PubMed ID: 2543866
[TBL] [Abstract][Full Text] [Related]
9. Protective immunization of mice with specific HSV-1 glycoproteins.
Chan WL
Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
[TBL] [Abstract][Full Text] [Related]
10. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
Alexander TS; Rosenthal KS
J Lab Clin Med; 1990 Sep; 116(3):400-7. PubMed ID: 2169516
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
Leung KN; Nash AA; Sia DY; Wildy P
Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
[TBL] [Abstract][Full Text] [Related]
12. The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice.
Berra A; Rodriguez A; Heiligenhaus A; Pazos B; Van Rooijen N; Foster CS
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2990-8. PubMed ID: 7911460
[TBL] [Abstract][Full Text] [Related]
13. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression of mice by cyclophosphamide (CyP) and cyclosporin A (CsA) changes the course of HSV-1 infection and the distribution of viral DNA in target organs.
Berkowitz-Balshayi C; Rösen-Wolff A; Darai G; Becker Y
In Vivo; 1995; 9(2):155-62. PubMed ID: 7548792
[TBL] [Abstract][Full Text] [Related]
15. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.
Carter VC; Schaffer PA; Tevethia SS
J Immunol; 1981 May; 126(5):1655-60. PubMed ID: 6971309
[TBL] [Abstract][Full Text] [Related]
16. Limiting dilution analysis of specific in vitro anti-herpes simplex virus antibody production by human lymphocytes.
Yasukawa M; Kobayashi Y
Clin Exp Immunol; 1987 Apr; 68(1):39-47. PubMed ID: 2820632
[TBL] [Abstract][Full Text] [Related]
17. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
Nash AA; Ashford NP
Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
[TBL] [Abstract][Full Text] [Related]
18. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Chan WL; Lukig ML; Liew FY
J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus latency in immunosuppressed mice.
Rotula A; Di Luca D; Gerna G; Manservigi R; Tognon M; Cassai E
Microbiologica; 1984 Jul; 7(3):219-27. PubMed ID: 6094985
[TBL] [Abstract][Full Text] [Related]
20. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
Roberts PL; Duncan BE; Raybould TJ; Watson DH
J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
